Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk model-Reference-Cited by-同舟云学术

Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk model

Published:2016-07-22 Issue:3 Volume:179 Page:508-510
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kansara Roopesh¹,Villa Diego¹,Gerrie Alina S.¹²,Klasa Richard¹,Shenkier Tamara¹,Scott David W.¹,Slack Graham W.³,Gascoyne Randy D.³,Connors Joseph M.¹,Sehn Laurie H.¹,Savage Kerry J.¹

Affiliation:

1. Centre for Lymphoid Cancer and Department of Medical Oncology; British Columbia Cancer Agency; Vancouver BC Canada

2. Leukemia/Bone Marrow Transplant Program of British Columbia; British Columbia Cancer Agency; Vancouver BC Canada

3. Centre for Lymphoid Cancer and Department of Pathology; British Columbia Cancer Agency; Vancouver BC Canada

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14229/fullpdf

Reference7 articles.

1. CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the german high-grade non-hodgkin lymphoma study group (DSHNHL);Boehme;Blood,2009

2. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: analyses with competing risk regression model;Chihara;Leukemia & Lymphoma,2011

3. CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the mabthera international trial and trials of the german high-grade non-hodgkin lymphoma study group;Schmitz;Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO,2012

4. The central nervous system international prognostic index (CNS-IPI) - a risk model for CNS relapse in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP;Schmitz;Journal of Clinical Oncology,2016

5. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity;Sehn;Blood,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diffuse large B-cell lymphoma with contemporary involvement of central and peripheral nervous system: A case report and literature review;Heliyon;2024-04

2. Relapsed isolated CNS lymphoma treated with radiotherapy and intrathecal methotrexate followed by high‐dose intravenous methotrexate, rituximab, and temozolomide: A case report;Clinical Case Reports;2024-03

3. High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma;Journal of Clinical Oncology;2023-12-10

4. Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse;Hematological Oncology;2023-06-29

5. CNS prophylaxis in aggressive B-cell lymphoma;Hematology;2022-12-09